[Prognostic factors of celiac disease occurrence in type 1 diabetes mellitus children]

Małgorzata Myśliwiec1, Anna Balcerska, Jan Stepiński

  • 1Klinika Pediatrii, Hematologii, Onkologii i Endokrynologii AM w Gdańsku, Gdańsk. mysliwiec@amg.gda.pl

Endokrynologia, Diabetologia I Choroby Przemiany Materii Wieku Rozwojowego : Organ Polskiego Towarzystwa Endokrynologow Dzieciecych
|January 24, 2007
PubMed

Insights

Celiac disease affects nearly 10% of children with type 1 diabetes (DM1). Tissue transglutaminase (TGA) antibody testing is the most sensitive method for screening celiac disease in this population.

Area of Science:

  • Pediatric Endocrinology
  • Gastroenterology
  • Immunology

Context:

  • Type 1 diabetes mellitus (DM1) and celiac disease frequently coexist in children.
  • Standardizing diagnostic methods for celiac disease in DM1 patients is crucial.
  • The Pomeranian region of Poland serves as the study's geographical focus.

Purpose:

  • To determine the incidence of celiac disease among children with DM1 in Poland.
  • To identify prognostic factors for celiac disease development in children with DM1.
  • To evaluate the effectiveness of various serological markers for celiac disease screening.

Summary:

  • A study involving 293 children with DM1 (newly diagnosed and long-standing) assessed celiac disease incidence and associated factors.
  • Jejunal biopsies confirmed celiac disease in 5.7% of newly diagnosed and 9.4% of long-standing DM1 patients.
  • Tissue transglutaminase (TGA) antibodies demonstrated the highest sensitivity (95.2%) for celiac disease detection in DM1 children.

Impact:

  • Highlights the significant prevalence of celiac disease in children with DM1, underscoring the need for routine screening.
  • Identifies TGA as a highly sensitive serological marker for early celiac disease detection in this high-risk group.
  • Provides valuable data for clinical practice guidelines regarding the management of comorbidities in pediatric DM1.
Abstract

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...